Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples From Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease
PLoS ONE - United States
doi 10.1371/journal.pone.0056422
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 19, 2013
Authors
Publisher
Public Library of Science (PLoS)